Abstract
As social phobia has become clinically more clearly characterized, the search for biologic features of the disorder has been instituted. As with most psychiatric disorders, this undertaking is difficult, because of the heterogeneity of the disorder in affected individuals. However, with investigation into several different areas, i.e., the neuroendocrine system, neurotransmitter function via naturalistic challenges, chemical and pharmacologic probes, response to pharmacologic interventions, and neuroimaging, theories about the biologic characteristics of social phobia have been advanced. Neuroendocrine studies have not yet revealed any clear abnormalities specific to individuals with social phobia. Based on studies of neurotransmitter functions and pharmacologic response, the major neurotransmitter systems that have been implicated are the serotonergic, dopaminergic, and noradrenergic. Neuroimaging studies have demonstrated possible structural and metabolic differences in some patients with social phobia.
Similar content being viewed by others
References
Black B, Uhde TW, Tancer ME (1992) Fluoxetine for the treatment of social phobia (letter). J Clin Psychopharmacol 12(4): 293–295
Blier P, Montigny C de, Chaput Y (1987) Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. J Clin Psychopharmacol 7:24S-35S
Brantigan CO, Brantigan TA, Joseph N (1982) Effects of betablockade and beta-stimulation on stage fright. Am J Med 72: 88–94
Davidson JRT, Boyko O, Charles HC, Krishnan KRR, Potts N, Ford S, Patterson L (1993) Magnetic resonance spectroscopy in social phobia. J Clin Psychiatry 54 (12, Suppl): 19–25
Davidson JRT, Ford SM, Smith RD, Potts NLS (1991) Long-term treatment of social phobia with clonazepam. J Clin Psychiatry 52 (11, Suppl): 16–20
Davidson JRT, Potts N, Richichi E, Krishnan R, Ford S, Smith R, Wilson WH (1993) Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 13: 423–428
Desai N, Taylor-Davies A, Barnett DB (1983) The effects of diazepam and oxprenolol on short-term memory in individuals of high- and low-state anxiety. Br J Clin Pharmacol 15: 197–202
American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders (DSM-III). American Psychiatric Association, Washington, D.C.
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders (DSM-III-R) 3rd edn revised. American Psychiatric Association, Washington, D.C.
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders (DSM-IV) 4th edn. American Psychiatric Association, Washington, D.C.
Dimsdale JE, Moss J (1980a) Short-term catecholamine response to psychological stress. Psychosomatic Med 42: 493–497
Dimsdale JE, Moss J (1980b) Plasma catecholamines in stress and exercise. JAMA 243: 340–342
Gelernter CS, Uhde TW, Cimbolic P, Arnkoff DB, Vittone BJ, Tancer ME, Bartko JJ (1991) Cognitive-behavioral and pharmacological treatments of social phobia: a controlled study. Arch Gen Psychiatry 48: 938–945
Goldstein S (1987) Treatment of social phobia with clonidine. Biol Psychiatry 22: 369–372
Gorman JM, Fyer MA, Goetz R, Askanazi N, Liebowitz MR, Fyer A, Kinney J, Klein DF (1988) Ventilatory physiology of patients with panic disorder. Arch Gen Psychiatry 45: 31–39
Gottschalk LA, Stone WN, Gleser CG (1974) Peripheral versus central mechanisms accounting for antianxiety effects of propranolol. Psychosom Med 36(1): 47–56
Hartley LR, Ungapen S, Davies I, Spencer DJ (1983) The effect of beta adrenergic blocking drugs on speakers' performance and memory. Br J Psychiatry 142: 512–517
James IM, Burgoyne W, Savage IT (1983) Effect of pindolol on stress-related disturbances of musical performance: preliminary communication. J Soc Med 76: 194–196
James IM, Griffith DN, Pearson RM, Newby P (1977) Effects of oxprenolol on stage fright in musicians. Lancet 2: 952–954
Krishnan G (1974) Oxprenolol in the treatment of examination nerves. Scott Med J 20: 288–289
Krope P, Kohrs A, Ott H, Wagner W, Fichte K (1982) Evaluating mepindolol in a test model of examination anxiety in students. Pharmacopsychiatrica 15: 41–47
Liebowitz MR, Quitkin FM, Stewart JW (1984) Phenelzine versus imipramine in atypical depression: a preliminary report. Arch Gen Psychiatry 44: 669–677
Liebowitz MR, Fyer AJ, Gorman JM, Dillon D, Davies S, Stein JM, Cohen BS, Klein DF (1985) Specificity of lactate infusions in social phobia versus panic disorder. Am J Psychiatry 142(8): 947–950
Lima L (1991) Region-selective reduction of brain serotonin turnover rate and serotonin agonist-induced behavior in mice treated with clonazepam. Pharmacol Biochem Behav 39(3): 671–676
Mikkelsen EJ, Deltor J, Cohen DJ (1981) School avoidance and social phobia triggered by haloperidol in patients with Tourette's syndrome. Am J Psychiatry 138(120): 1572–1576
Munjack DJ, Baltazar PL, Bohn PB, Cabe DD, Appleton AA (1990) Clonazepam in the treatment of social phobia: a pilot study. J Clin Psychiatry 51(5 Suppl): 35–53
Munjack DJ, Bruns J, Baltazar PL, Brown R, Leonard M, Nagy R, Koek R, Crocker B, Schafer S (1991) A pilot study of buspirone in the treatment of social phobia. J Anxiety Disord 5: 87–98
Neftel KA, Adler RH, Kappell L, Rossi M, Dolder M, Kaser HE, Bruggesser HH, Vorkauf H (1982) Stage fright in musicians: a model illustrating the effects of beta blockers. Psychosom Med 44: 461–469
Papp LA, Gorman JM, Liebowitz MR, Fyer AJ, Cohen B, Klein DF (1988) Epinephrine infusions in patients with social phobia. Am J Psychiatry 146(6): 733–736
Potts NL, Davidson JR, Krishnan KR, Doraiswamy PM, Ritchie JC (1991) Levels of urinary-free cortisol in social phobia. J Clin Psychiatry 52 (Suppl): 41–42
Pratt J, Lenner P, Reynolds EH, Marsden CD (1979) Clonazepam induces decreased serotonergic activity in the mouse brain. Neuropharmacology 18: 791–799
Reich JR, Yates W (1988) A pilot study of treatment of social phobia with alprazolam. Am J Psychiatry 145(5): 590–594
Reich JR, Noyes R, Yates W (1989) Alprazolam treatment of avoidant personality traits in social phobic patients. J Clin Psychiatry 50(3): 991–995
Schneier FR, Chin SJ, Hollander E, Liebowitz MR (1992) Fluoxetine in social phobia (letter). J Clin Psychopharmacology 12(1): 62–63
Schneier FR, Saoud JB, Campeas R, Fallon BA, Hollander E, Coplan J, Liebowitz MR (1993) Buspirone in social phobia. J Clin Psychopharmacol 13(4) 251–256
Siitonen L, Jane J (1976) Effect of beta-blockade during bowling competitions. Am Clin Res 8: 393–398
Stein MB, Tancer ME, Uhde TW (1992) Heart rate and plasma norepinephrine responsivity to orthostatic challenge in anxiety disorders. Arch Gen Psychiatry 49: 311–317
Tancer ME (1993) Neurobiology of social phobia. J Clin Psychiatry 54 (12, Suppl): 26–30
Tancer ME, Uhde TW (1989) Neuroendocrine, physiologic, and behavioral responses to clonidine in patients with social phobia. Biol Psychiatry 25: 189A
Tancer ME, Stein MB, Uhde TW (1990a) Effects of thyrotropin-releasing hormone on blood pressure and heart rate in social phobia patients, panic disorder patients, and normal controls: results of a pilot study. Biol Psychiatry 27(7): 781–783
Tancer ME, Stein MB, Gelernter CS, Uhde TW (1990b) The hypothalamic-pituitary-thyroid axis in social phobia. Am J Psychiatry 147: 929–933
Tancer ME, Stein MB, Uhde TW (1991) Lactate response to caffeine in panic disorder: a replication using an “anxious” control group. Biol Psychiatry 29: 57A (Abstract)
Uhde TW, Tancer ME (1994) Normal urinary-free cortisol and postdexamethasone cortisol in social phobia. J Affect Disord 30: 155–161
Van Amerigen M, Mancini C, Streiner DL (1993) Fluoxetine efficacy in social phobia. J Clin Psychiatry 54(1): 27–32
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miner, C.M., Davidson, J.R.T. Biological characterization of social phobia. Eur Arch Psychiatry Clin Nuerosci 244, 304–308 (1995). https://doi.org/10.1007/BF02190408
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02190408